- Home
- Advocacy
- Latest News and Practice Data
- Pathologists Who Rely on MIPS Facility-based Scores Must Urgently Find an Alternative for 2022
In the final 2023 Inpatient Prospective Payment System (IPPS) /Long-Term Care Hospital Prospective Payment System (LTCH PPS) regulation, the CMS phased out several measures in the Hospital Value-Based Purchasing (VBP) Program due to the effect of COVID-19 on measure performance. Therefore, the CMS will not calculate the MIPS facility-based scores for the 2022 MIPS performance year.
The CMS understands that calculating a total performance score in the Hospital VBP Program for hospitals using only data from the remaining measures would not result in a fair national comparison. Therefore, the CMS will not calculate a 2023 total performance score under the Hospital VBP Program for any hospital affecting the MIPS facility-based score.
The CMS will not calculate the MIPS facility-based scores for the 2022 MIPS performance year because the 2023 total performance score from the Hospital VBP Program won’t be available. Facility-based clinicians and groups must collect and submit MIPS quality measures to receive a score other than zero for the quality performance category.
If a pathology practice has used facility-based scoring, the practice will need a different mechanism to submit MIPS. Pathologists and their practices can check their MIPS eligibility.
Facility-based clinicians and groups without available and applicable measures can request performance category reweighting by submitting a 2022 MIPS Extreme and Uncontrollable Circumstances Exception application. For more information, please visit the CMS Quality Payment Program or contact mips@cap.org with specific questions.